Department of Oncology, Baoan Central Hospital of Shenzhen, the 5th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3795-3804. doi: 10.26355/eurrev_202004_20845.
The aim of this study was to explore the function of microRNA-548c-5p in breast cancer (BCa) and the underlying mechanism. Our findings might help to provide a theoretical basis for the diagnosis and treatment of BCa.
Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the expression level of microRNA-548c-5p in BCa tumor tissues and para-cancerous tissues. The relationship between microRNA-548c-5p expression and clinical indicators of BCa was analyzed. Meanwhile, the expression of microRNA-548c-5p in the BCa cells was detected by qRT-PCR as well. MicroRNA-548c-5p overexpression and the knockdown models were constructed in BCa cell lines MCF-7 and MDA-MB-231. Subsequently, Cell Counting Kit-8 (CCK-8), colony formation and 5-ethynyl-2'-deoxyuridine (EdU) assays were performed to analyze the influence of microRNA-548c-5p on biological functions of BCa cells. Finally, the interaction between microRNA-548c-5p and Wnt/b-catenin signaling pathway was investigated.
QRT-PCR results showed that the expression level of microRNA-548c-5p in BCa tumor tissues was remarkably lower than that of adjacent tissues, and the difference was statistically significant (p<0.05). Compared with patients with high expression of microRNA-548c-5p, the pathological stage of patients with low microRNA-548c-5p expression was significantly higher (p<0.05). Similarly, microRNA-548c-5p overexpression remarkably decreased the proliferation ability of BCa cells in vitro. However, microRNA-548c-5p knockdown showed an opposite trend. In addition, Wnt1, a key factor in the Wnt/b-catenin signaling pathway, was found remarkably up-regulated in BCa cell lines and tissues. Wnt1 expression was negatively correlated with microRNA-548c-5p expression. Western Blotting results demonstrated that microRNA-548c-5p mimics remarkably down-regulated the levels of the proteins in the Wnt/b-catenin signaling pathway. Conversely, opposite results were observed in microRNA-548c-5p inhibitor group. The rescue experiments in the cells revealed that there might be a mutual regulation between microRNA-548c-5p and Wnt1, thereby together regulating the malignant growth of BCa.
MicroRNA-548c-5p was lowly expressed in BCa tissues and cells, which was closely related to the pathological stage of BCa. In addition, microRNA-548c-5p significantly inhibited the proliferation of BCa cells via modulating Wnt/b-catenin signaling pathway.
本研究旨在探讨微小 RNA-548c-5p 在乳腺癌(BCa)中的功能及其潜在机制。我们的研究结果可能有助于为 BCa 的诊断和治疗提供理论依据。
采用实时定量聚合酶链反应(qRT-PCR)检测 BCa 肿瘤组织和癌旁组织中微小 RNA-548c-5p 的表达水平。分析微小 RNA-548c-5p 表达与 BCa 临床指标的关系。同时,采用 qRT-PCR 检测 BCa 细胞中微小 RNA-548c-5p 的表达。在 MCF-7 和 MDA-MB-231 细胞系中构建微小 RNA-548c-5p 过表达和敲低模型。随后,通过细胞计数试剂盒-8(CCK-8)、集落形成和 5-乙炔基-2'-脱氧尿苷(EdU)检测分析微小 RNA-548c-5p 对 BCa 细胞生物学功能的影响。最后,研究微小 RNA-548c-5p 与 Wnt/β-catenin 信号通路的相互作用。
qRT-PCR 结果显示,BCa 肿瘤组织中微小 RNA-548c-5p 的表达水平明显低于邻近组织,差异具有统计学意义(p<0.05)。与微小 RNA-548c-5p 高表达患者相比,微小 RNA-548c-5p 低表达患者的病理分期明显更高(p<0.05)。同样,微小 RNA-548c-5p 过表达显著降低了 BCa 细胞在体外的增殖能力。然而,微小 RNA-548c-5p 敲低则呈现出相反的趋势。此外,Wnt1,Wnt/β-catenin 信号通路中的关键因子,在 BCa 细胞系和组织中表达明显上调。Wnt1 表达与微小 RNA-548c-5p 表达呈负相关。Western Blotting 结果表明,微小 RNA-548c-5p 模拟物显著下调了 Wnt/β-catenin 信号通路中蛋白的水平。相反,微小 RNA-548c-5p 抑制剂组则观察到相反的结果。细胞中的挽救实验表明,微小 RNA-548c-5p 和 Wnt1 之间可能存在相互调节作用,从而共同调节 BCa 的恶性生长。
微小 RNA-548c-5p 在 BCa 组织和细胞中低表达,与 BCa 的病理分期密切相关。此外,微小 RNA-548c-5p 通过调节 Wnt/β-catenin 信号通路显著抑制 BCa 细胞的增殖。